Hangzhou Tigermed Consulting Co., Ltd (HKG:3347)
51.85
-0.55 (-1.05%)
Jan 21, 2026, 1:25 PM HKT
HKG:3347 Market Cap
HKG:3347 has a market cap or net worth of 55.69 billion as of January 20, 2026. Its market cap has increased by 10.34% in one year.
Market Cap
55.69B
Enterprise Value
59.69B
Revenue
7.17B
Ranking
n/a
PE Ratio
83.24
Stock Price
51.85
Market Cap Chart
Since August 17, 2012, HKG:3347's market cap has increased from 2.44B to 55.69B, an increase of 2,182.93%. That is a compound annual growth rate of 26.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 55.69B | 8.29% |
| Dec 31, 2025 | 51.43B | 10.12% |
| Dec 31, 2024 | 46.70B | -5.40% |
| Dec 29, 2023 | 49.36B | -50.14% |
| Dec 30, 2022 | 98.99B | -22.60% |
| Dec 31, 2021 | 127.90B | -22.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |